177 Lu-FAP-2286 Therapy in a Patient of Advanced Metastatic Malignant Solitary Fibrous Tumor.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 42411765.
- Also identified by DOI 10.1097/RLU.0000000000006609.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Solitary fibrous tumor (SFT) is a mesenchymal tumor with unpredictable biological behavior that can occur in multiple anatomic sites throughout the body. This case report describes a 22-year-old man with an intracranial malignant solitary fibrous tumor. After 3 courses of 177 Lu-FAP-2286 therapy, 68 Ga-FAP-2286 PET/CT revealed partial tumor regression, with the patient reporting no adverse reactions.
Medical subject headings
- Solitary Fibrous Tumors
- Lutetium
- Radioisotopes